BioSpace News Archive

EVERFI, the leading social impact education innovator, will host its second annual Prescription Drug Safety Network (PDSN) Summit in Washington. D.C.

Media representatives are advised that The Leukemia & Lymphoma Society of Canada and Max Parrot, professional snowboarder and Olympic silver medalist, diagnosed with Hodgkin lymphoma, will make an announcement at a press conference.

Veloxis Pharmaceuticals A/S (OMX: VELO) today published its Interim Report for the first three months of 2019.

Nuvera Life Science Consulting is a consulting company dedicated to helping the world’s leading pharmaceutical and biotech companies deliver impactful patient and HCP support experiences for specialty and rare-disease therapies.

Vytronus, Inc., a privately held medical device company developing novel technologies for the treatment of cardiac arrhythmias, announced today that it will exhibit at the Heart Rhythm Society 2019 annual meeting being held this year in San Francisco from May 8–11.

The Public Access to SunScreens Coalition, an alliance of public health organizations, physician groups, sunscreen manufacturers and concerned citizens, would like to remind all Americans that sunscreen is a critical tool to reduce risk of melanoma, other skin cancers and premature aging.

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, today announced that the first quarter result’s press release will be released at 6:03 a.m. (ET) on Monday, May 13th

Former DOJ litigator Jonathan Novak will explain distributor responsibility

Six-Year, Multi-Center, Pivotal Clinical Trial Data of LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg Presented at 2019 ACOG Meeting

LindaCare, a digital health company specializing in development of remote patient monitoring solutions for chronic disease management, announces at the Heart Rhythm Society Scientific Sessions it has added two of the world’s leading experts in cardiac implantable device management to its Medical Advisory Board: Bruce Wilkoff, MD, and Charles Love, MD,